The value of biomarker-guided antibiotic therapy.

Expert Review of Molecular Diagnostics
Ellen HaagPhilipp Schuetz

Abstract

There is an increasing interest to individualize patient management and decisions regarding antibiotic treatment. Biomarkers may provide relevant information for this purpose. Despite a growing number of clinical trials investigating several biomarkers, there remain open questions regarding the best type of biomarker, timing or frequency of testing, and optimal cutoffs among others. The most promising results in regard to diagnosis of bacterial infection and therapy monitoring are found for procalcitonin (PCT), although some recent trials were not able to validate the promising earlier findings. Furthermore, less specific markers like C-reactive protein (CRP) and new prognostic biomarkers such as proadrenomedullin (MR-proADM) may improve the prognostic assessment of patients and proteomics may help shorten time to microbiological results. The aim of this review is to summarize the current concept of biomarker-guided management and provide an outlook of promising ongoing investigations. 'Antibiotic stewardship' is complex and needs more than just the measurement of one single biomarker. However, when integrated into the context of a thorough clinical examination, standard blood parameters and a well done risk stratification by c...Continue Reading

References

Apr 30, 1993·Biochemical and Biophysical Research Communications·K KitamuraT Eto
Oct 3, 1998·Intensive Care Medicine·F M BrunkhorstZ F Forycki
Mar 9, 2000·Critical Care Medicine·M W NijstenJ H Zwaveling
Apr 27, 2000·Endocrine Reviews·J P HinsonD M Smith
Feb 7, 2001·Journal of Clinical Microbiology·W A Al-Soud, P Rådström
Jan 17, 2002·The New England Journal of Medicine·E RiversUNKNOWN Early Goal-Directed Therapy Collaborative Group
Feb 13, 2004·The New England Journal of Medicine·Christian MuellerAndré P Perruchoud
Oct 14, 2006·Critical Care : the Official Journal of the Critical Care Forum·Christoph SponholzFrank Brunkhorst
Dec 15, 2007·Intensive Care Medicine·Martijn D de KruifTom van der Poll
Aug 5, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J HaeuptleP Schuetz
Sep 10, 2009·JAMA : the Journal of the American Medical Association·Philipp SchuetzUNKNOWN ProHOSP Study Group
Dec 30, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P SchuetzB Müller
Jan 6, 2010·The Journal of Bone and Joint Surgery. American Volume·Sabina HunzikerAndrej Trampuz
Apr 8, 2010·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Marek NemecRoland Bingisser
Jul 3, 2010·The European Respiratory Journal·P SchuetzUNKNOWN Procalcitonin-Guided Antibiotic Therapy and Hospitalisation in Patients with Lower Respiratory Tract Infections (ProHOSP) St
Sep 18, 2010·Journal of the American College of Cardiology·Mira KatanMirjam Christ-Crain
Nov 19, 2010·Critical Care : the Official Journal of the Critical Care Forum·Cees van NieuwkoopJaap T van Dissel
Mar 29, 2011·Critical Care Clinics·Brian CasserlyMitchell M Levy
Apr 7, 2011·Nature Reviews. Rheumatology·Benjamin RhodesTimothy J Vyse
May 17, 2011·Critical Care Medicine·Michael A PuskarichUNKNOWN Emergency Medicine Shock Research Network (EMSHOCKNET)
Jun 21, 2011·Critical Care Medicine·Maria E JohansenJens D Lundgren
Oct 6, 2011·European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine·Jan Florian HeuerMarkus Roessler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.